US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
TG Therapeutics Inc (TGTX)
TG Therapeutics Inc (TGTX) ニュース

TGTX

TG Therapeutics (TGTX)

TG Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TGTX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/01	20 : 00	GlobeNewswire Inc.	TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results	NASDAQ:TGTX	TG Therapeutics Inc
2024/05/01	05 : 55	GlobeNewswire Inc.	TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update	NASDAQ:TGTX	TG Therapeutics Inc
2024/04/18	20 : 30	GlobeNewswire Inc.	TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting	NASDAQ:TGTX	TG Therapeutics Inc
2024/04/18	20 : 00	GlobeNewswire Inc.	TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis	NASDAQ:TGTX	TG Therapeutics Inc
2024/04/15	20 : 30	GlobeNewswire Inc.	TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting	NASDAQ:TGTX	TG Therapeutics Inc
2024/03/08	21 : 30	GlobeNewswire Inc.	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting	NASDAQ:TGTX	TG Therapeutics Inc
2024/03/01	21 : 30	GlobeNewswire Inc.	TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum	NASDAQ:TGTX	TG Therapeutics Inc
2024/03/01	07 : 23	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TGTX	TG Therapeutics Inc
2024/02/28	21 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TGTX	TG Therapeutics Inc
2024/02/28	21 : 00	GlobeNewswire Inc.	TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results	NASDAQ:TGTX	TG Therapeutics Inc
2024/02/27	21 : 30	GlobeNewswire Inc.	TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)	NASDAQ:TGTX	TG Therapeutics Inc
2024/02/26	21 : 00	GlobeNewswire Inc.	TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)	NASDAQ:TGTX	TG Therapeutics Inc
2024/02/23	21 : 30	GlobeNewswire Inc.	TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update	NASDAQ:TGTX	TG Therapeutics Inc
2024/02/20	21 : 30	GlobeNewswire Inc.	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum	NASDAQ:TGTX	TG Therapeutics Inc
2024/02/15	11 : 53	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	NASDAQ:TGTX	TG Therapeutics Inc
2024/02/15	05 : 30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/27	06 : 23	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/10	21 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/10	21 : 00	GlobeNewswire Inc.	TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/09	23 : 20	AllPennyStocks.com	Biotech Massively Bid Up Before Opening Bell	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/09	21 : 00	GlobeNewswire Inc.	TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseases	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/09	08 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/09	08 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/06	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/06	01 : 02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/05	21 : 30	GlobeNewswire Inc.	TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:TGTX	TG Therapeutics Inc
2024/01/04	06 : 46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TGTX	TG Therapeutics Inc
2023/11/27	21 : 30	GlobeNewswire Inc.	TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference	NASDAQ:TGTX	TG Therapeutics Inc
2023/11/07	07 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TGTX	TG Therapeutics Inc
2023/11/03	20 : 30	GlobeNewswire Inc.	TG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference	NASDAQ:TGTX	TG Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:TGTX

1 2 3 4 5 6 7 8 9 10 次へ >>

BNP Paribas (QX)

Invesco QQQ Trust Series 1

American Express

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約